Quality of life in patients with gastroenteropancreatic tumors treated with [177Lu-DOTA0,Tyr3]octreotate

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Jaap J M TeunissenEric P Krenning

Abstract

To evaluate the quality of life (QoL) in patients with metastatic somatostatin receptor positive gastroenteropancreatic tumors treated with [(177)Lu-DOTA(0),Tyr(3)]octreotate ((177)Lu-octreotate) therapy. Fifty patients who had been treated with 600 to 800 mCi of (177)Lu-octreotate and had a follow-up of at least 3 months were studied. The patients completed the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire C30 before therapy and at follow-up visit 6 weeks after the last cycle. Overall QoL and specific QoL domains of both the total group of patients and subgroups according to treatment outcome were analyzed. Twenty-four patients had regression, 19 had stable disease, six had progressive disease, and one had nonassessable disease status. Analysis of variance was used for statistical comparison. A significant improvement in the global health status/QoL scale was observed after therapy with (177)Lu-octreotate (P <.01). The score increased significantly six weeks after therapy to a mean of 78.2, up from 69.0 (scale range, 0 to 100). Furthermore, significant improvement was observed in the role, emotional, and social function scales. The symptom scores for fatigue, insomnia, and pain we...Continue Reading

References

Dec 1, 1994·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·J Schaafsma, D Osoba
Mar 1, 1996·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A GlausS Hammond
Jun 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A CoatesD Osoba
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D OsobaJ Pater
Apr 29, 1998·Statistics in Medicine·P M FayersD Machin
Nov 3, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K KobayashiK Yoshida
Mar 18, 1999·The New England Journal of Medicine·M H Kulke, R J Mayer
Nov 30, 2000·The American Journal of Gastroenterology·M DucreuxP Rougier
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Savard, C M Morin
Jan 29, 2002·Lancet·Peter M Fayers, Mirjam A G Sprangers
Jul 24, 2002·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Gary R MorrowSara Matteson
Mar 11, 2003·The Oncologist·Ann Berger
Mar 14, 2003·European Journal of Nuclear Medicine and Molecular Imaging·D J KwekkeboomE P Krenning
May 29, 2003·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·E Crocetti, E Paci

❮ Previous
Next ❯

Citations

Feb 3, 2005·European Journal of Nuclear Medicine and Molecular Imaging·F ForrerH Maecke
Sep 6, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Lisa BodeiGiovanni Paganelli
Mar 6, 2012·European Journal of Nuclear Medicine and Molecular Imaging·B L R KamD J Kwekkeboom
Oct 3, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sung KimYoung Ho Yun
Mar 4, 2011·Cancer Metastasis Reviews·Michael D CullerJosé Angel Díaz
Sep 11, 2012·Annals of Nuclear Medicine·Sofie Van BinnebeekChristophe M Deroose
Jun 3, 2009·Nature Reviews. Endocrinology·Martijn van EssenDik J Kwekkeboom
Jun 30, 2007·Cancer Biotherapy & Radiopharmaceuticals·Helena UusijärviEva Forssell-Aronsson
May 6, 2008·Cancer Biotherapy & Radiopharmaceuticals·Monique de VisserMarion de Jong
Nov 30, 2006·Current Opinion in Oncology·Elijah Dixon, Janice L Pasieka
Apr 7, 2009·American Journal of Clinical Oncology·David M LiuRiad Salem
Jul 1, 2011·International Journal of Molecular Imaging·Gunnar HerlinRimma Axelsson
Jan 13, 2012·Neuroendocrinology·Esther I van VlietDik J Kwekkeboom
Oct 26, 2011·Endocrine-related Cancer·Jaap J M TeunissenEric P Krenning
Oct 28, 2009·World Journal of Gastroenterology : WJG·Raffaele PezzilliPaola Tomassetti
Apr 10, 2010·World Journal of Gastroenterology : WJG·Gilles PoncetThomas Walter
Oct 9, 2013·European Journal of Nuclear Medicine and Molecular Imaging·Cristina MüllerRoger Schibli
Jul 29, 2009·Journal of Endocrinological Investigation·L BodeiG Paganelli
Feb 27, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Madhav DanthalaM Raghavendra Rao
Oct 10, 2013·Thyroid : Official Journal of the American Thyroid Association·Annibale VersariPaola Anna Erba
Nov 17, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Edgar J RollemanMarion de Jong
Feb 3, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Cristina MüllerRoger Schibli
Oct 6, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Edgar J RollemanMarion de Jong
Dec 6, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Edgar J RollemanMarion de Jong
Jul 19, 2006·European Journal of Nuclear Medicine and Molecular Imaging·J P EsserD J Kwekkeboom
Jul 30, 2014·Thoracic Surgery Clinics·Lisa BodeiGiovanni Paganelli
Jan 14, 2016·Future Oncology·Daniel M HalperinJames C Yao
Jul 23, 2013·Frontiers in Neuroendocrinology·Marily Theodoropoulou, Günter K Stalla
Feb 26, 2011·Endocrinology and Metabolism Clinics of North America·Dik J KwekkeboomEric P Krenning
Feb 26, 2011·Endocrinology and Metabolism Clinics of North America·Guillaume NicolasFlavio Forrer
Mar 31, 2010·Seminars in Nuclear Medicine·Stefan E PoolMarion de Jong
Feb 2, 2010·Seminars in Nuclear Medicine·Dik J KwekkeboomEric P Krenning
Oct 19, 2007·Molecular and Cellular Endocrinology·V A S H DalmS W J Lamberts
Sep 29, 2007·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Z DvorakovaH Gerstenberg
Mar 27, 2007·Best Practice & Research. Clinical Endocrinology & Metabolism·Flavio ForrerEric P Krenning
Mar 15, 2016·Best Practice & Research. Clinical Endocrinology & Metabolism·Tessa BrabanderDik J Kwekkeboom
Apr 25, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Irvin M ModlinGeeta Eick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Dik J KwekkeboomEric P Krenning
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Dik J KwekkeboomEric P Krenning
© 2022 Meta ULC. All rights reserved